DOI:
10.1055/s-00000031
Klinische Monatsblätter für Augenheilkunde
LinksClose Window
References
Joussen AM, Wolf S, Kaiser PK, Boyer DS. et al.
A combined phase 2a/b study of the efficacy, safety, and tolerability of repeated topical doses of regorafenib eye drops in treatment-naïve patients with neovascular age-related macular degeneration (nAMD).
Invest Ophthalmol Vis Sci 2016;
57: 658
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.